Tenet Healthcare Corporation (NYSE:THC) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Tenet Healthcare Corporation (NYSE:THC) have earned an average rating of “Moderate Buy” from the twenty-one brokerages that are covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold recommendation and seventeen have given a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $244.8421.

THC has been the subject of several recent analyst reports. Royal Bank Of Canada decreased their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Guggenheim reduced their price target on shares of Tenet Healthcare from $252.00 to $242.00 and set a “buy” rating for the company in a research report on Monday. Wells Fargo & Company increased their target price on Tenet Healthcare from $213.00 to $231.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. TD Cowen lowered their price target on Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Finally, Weiss Ratings lowered Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 2nd.

Tenet Healthcare Stock Down 0.3%

Shares of NYSE:THC opened at $195.84 on Thursday. Tenet Healthcare has a 12-month low of $146.60 and a 12-month high of $247.21. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The stock has a fifty day simple moving average of $184.41 and a two-hundred day simple moving average of $197.37. The stock has a market capitalization of $16.87 billion, a price-to-earnings ratio of 10.18, a PEG ratio of 1.63 and a beta of 1.27.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the previous year, the firm earned $4.36 EPS. Tenet Healthcare’s quarterly revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, research analysts anticipate that Tenet Healthcare will post 17.5 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the transaction, the director owned 16,804 shares in the company, valued at $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director directly owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.97% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Triumph Capital Management bought a new stake in shares of Tenet Healthcare during the 3rd quarter valued at about $25,000. Activest Wealth Management bought a new position in shares of Tenet Healthcare in the 4th quarter worth approximately $26,000. Elyxium Wealth LLC bought a new stake in Tenet Healthcare during the fourth quarter valued at approximately $29,000. Canada Pension Plan Investment Board purchased a new stake in Tenet Healthcare during the second quarter valued at approximately $35,000. Finally, Meeder Asset Management Inc. raised its position in Tenet Healthcare by 146.2% in the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after acquiring an additional 114 shares during the period. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.